Pharmacokinetics of cefmetazole administered intramuscularly and intravenously to healthy adults
- PMID: 3865631
- PMCID: PMC180302
- DOI: 10.1128/AAC.28.4.544
Pharmacokinetics of cefmetazole administered intramuscularly and intravenously to healthy adults
Abstract
The pharmacokinetics of cefmetazole, a new parenteral cephalosporin, administered intravenously and intramuscularly at a dose of 30 mg/kg to two groups of seven healthy volunteers were studied. Concentrations in serum were monitored over 8 h by a high-pressure liquid chromatography technique. The plasma concentration-time data were statistically fitted to a biexponential equation for both administration routes, and the data were analyzed by a two- and one-compartment kinetic model, respectively. For the dose range and the administration routes used, the pharmacokinetics of cefmetazole proved to be essentially linear, with clearances from plasma ranging between 3.8 and 12.5 liters/h. The mean maximum concentration in plasma after intramuscular administration of the drug was 90.1 micrograms/ml at 0.7 h. The elimination half-life, about 1.3 h, did not show statistically significant differences for the two routes of administration studied.
Similar articles
-
Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.Antimicrob Agents Chemother. 1989 Mar;33(3):356-61. doi: 10.1128/AAC.33.3.356. Antimicrob Agents Chemother. 1989. PMID: 2729930 Free PMC article. Clinical Trial.
-
Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.Antimicrob Agents Chemother. 1984 Oct;26(4):513-8. doi: 10.1128/AAC.26.4.513. Antimicrob Agents Chemother. 1984. PMID: 6097166 Free PMC article.
-
Pharmacokinetics of single-dose cefmetazole following intramuscular administration of cefmetazole sodium to healthy male volunteers.Antimicrob Agents Chemother. 1989 Apr;33(4):508-12. doi: 10.1128/AAC.33.4.508. Antimicrob Agents Chemother. 1989. PMID: 2729944 Free PMC article. Clinical Trial.
-
Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.Antimicrob Agents Chemother. 1982 Jul;22(1):94-102. doi: 10.1128/AAC.22.1.94. Antimicrob Agents Chemother. 1982. PMID: 6214998 Free PMC article.
-
Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function.Antimicrob Agents Chemother. 1980 Sep;18(3):386-9. doi: 10.1128/AAC.18.3.386. Antimicrob Agents Chemother. 1980. PMID: 6932824 Free PMC article.
Cited by
-
Pharmacokinetics of cefpirome (HR 810), a new cephalosporin derivative administered intramuscularly and intravenously to healthy volunteers.Infection. 1987 May-Jun;15(3):207-10. doi: 10.1007/BF01646052. Infection. 1987. PMID: 3610329 Clinical Trial.
-
Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel.J Pharm Anal. 2023 Oct;13(10):1205-1220. doi: 10.1016/j.jpha.2023.05.007. Epub 2023 May 15. J Pharm Anal. 2023. PMID: 38024860 Free PMC article.
-
Considerations in dosage selection for third generation cephalosporins.Clin Pharmacokinet. 1992 Feb;22(2):132-43. doi: 10.2165/00003088-199222020-00004. Clin Pharmacokinet. 1992. PMID: 1551290 Review.
-
Disposition of cefmetazole in healthy volunteers and patients with impaired renal function.Antimicrob Agents Chemother. 1990 Apr;34(4):519-23. doi: 10.1128/AAC.34.4.519. Antimicrob Agents Chemother. 1990. PMID: 2344159 Free PMC article.
-
Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.Antimicrob Agents Chemother. 1989 Mar;33(3):356-61. doi: 10.1128/AAC.33.3.356. Antimicrob Agents Chemother. 1989. PMID: 2729930 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources